These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37593376)

  • 1. Identification and quantitative assessment of motor complications in Parkinson's disease using the Parkinson's KinetiGraph™.
    Qu Y; Zhang T; Duo Y; Chen L; Li X
    Front Aging Neurosci; 2023; 15():1142268. PubMed ID: 37593376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. More Sensitive Identification for Bradykinesia Compared to Tremors in Parkinson's Disease Based on Parkinson's KinetiGraph (PKG).
    Chen L; Cai G; Weng H; Yu J; Yang Y; Huang X; Chen X; Ye Q
    Front Aging Neurosci; 2020; 12():594701. PubMed ID: 33240078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness analysis of the Parkinson's KinetiGraph and clinical assessment in the management of Parkinson's disease.
    Chaudhuri KR; Hand A; Obam F; Belsey J
    J Med Econ; 2022; 25(1):774-782. PubMed ID: 35593687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A method for measuring time spent in bradykinesia and dyskinesia in people with Parkinson's disease using an ambulatory monitor.
    Khodakarami H; Shokouhi N; Horne M
    J Neuroeng Rehabil; 2021 Jul; 18(1):116. PubMed ID: 34271971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Objective measurement in Parkinson's disease: a descriptive analysis of Parkinson's symptom scores from a large population of patients across the world using the Personal KinetiGraph®.
    Pahwa R; Bergquist F; Horne M; Minshall ME
    J Clin Mov Disord; 2020; 7():5. PubMed ID: 32377368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinically important change on the Unified Dyskinesia Rating Scale among patients with Parkinson's disease experiencing dyskinesia.
    Pahwa R; Fox S; Hauser RA; Isaacson S; Lytle J; Johnson R; Llorens L; Formella AE; Tanner CM
    Front Neurol; 2022; 13():846126. PubMed ID: 36341088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of Personal KinetiGraph™ fluctuator score in quantifying the progression of motor fluctuations in Parkinson's disease.
    Tan EE; Hogg EJ; Tagliati M
    Funct Neurol; 2019; 34(1):21-28. PubMed ID: 31172936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do neuropsychiatric fluctuations temporally match motor fluctuations in Parkinson's disease?
    Del Prete E; Schmitt E; Meoni S; Fraix V; Castrioto A; Pelissier P; Ceravolo R; Moro E
    Neurol Sci; 2022 Jun; 43(6):3641-3647. PubMed ID: 35043355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the Parkinson's KinetiGraph to off/on levodopa response testing: Single center experience.
    Guan I; Trabilsy M; Barkan S; Malhotra A; Hou Y; Wang F; Hellmers N; Sarva H; Henchcliffe C
    Clin Neurol Neurosurg; 2021 Oct; 209():106890. PubMed ID: 34455169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical correlates of movement disorders in adult Niemann-Pick type C patients measured via a Personal KinetiGraph.
    El-Masri S; Malpas CB; Evans A; Walterfang M
    Neurol Sci; 2022 Nov; 43(11):6339-6347. PubMed ID: 35945383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing Objective and Subjective Measures of Parkinson's Disease Using the Parkinson's KinetiGraph.
    Knudson M; Thomsen TH; Kjaer TW
    Front Neurol; 2020; 11():570833. PubMed ID: 33250843
    [No Abstract]   [Full Text] [Related]  

  • 12. Minimal clinically important difference for the historic parts of the Unified Dyskinesia Rating Scale.
    Makkos A; Kovács M; Pintér D; Janszky J; Kovács N
    Parkinsonism Relat Disord; 2019 Jan; 58():79-82. PubMed ID: 30174275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving Medication Regimen Recommendation for Parkinson's Disease Using Sensor Technology.
    Watts J; Khojandi A; Vasudevan R; Nahab FB; Ramdhani RA
    Sensors (Basel); 2021 May; 21(10):. PubMed ID: 34065245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Gocovri (Amantadine) Extended Release Capsules on Non-Motor Symptoms in Patients with Parkinson's Disease and Dyskinesia.
    Mehta SH; Pahwa R; Tanner CM; Hauser RA; Johnson R
    Neurol Ther; 2021 Jun; 10(1):307-320. PubMed ID: 33864229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy of MDS-UPDRS section IV for detecting motor fluctuations in Parkinson's disease.
    Raciti L; Nicoletti A; Mostile G; Bonomo R; Dibilio V; Donzuso G; Sciacca G; Cicero CE; Luca A; Zappia M
    Neurol Sci; 2019 Jun; 40(6):1271-1273. PubMed ID: 30737581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levodopa/carbidopa intestinal gel can improve both motor and non-motor experiences of daily living in Parkinson's disease: An open-label study.
    Juhász A; Aschermann Z; Ács P; Janszky J; Kovács M; Makkos A; Harmat M; Tényi D; Karádi K; Komoly S; Takáts A; Tóth A; Nagy H; Klivényi P; Dibó G; Dézsi L; Zádori D; Annus Á; Vécsei L; Varannai L; Kovács N
    Parkinsonism Relat Disord; 2017 Apr; 37():79-86. PubMed ID: 28185758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opicapone versus placebo in the treatment of Parkinson's disease patients with end-of-dose motor fluctuation-associated pain: rationale and design of the randomised, double-blind OCEAN (OpiCapone Effect on motor fluctuations and pAiN) trial.
    Chaudhuri KR; Odin P; Ferreira JJ; Antonini A; Rascol O; Kurtis MM; Storch A; Bannister K; Soares-da-Silva P; Costa R; Magalhães D; Rocha JF
    BMC Neurol; 2022 Mar; 22(1):88. PubMed ID: 35279112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The clinical efficacy of the stratification medical treatment based on the risk estimation of motor complications in Parkinson's disease].
    Wan Y; Xiao RQ; Zhao JH; Zhang Y; Gan J; Wu N; Song L; Li L; Qi C; Chen W; Wang XJ; Liu ZG
    Zhonghua Yi Xue Za Zhi; 2022 Feb; 102(7):491-498. PubMed ID: 35184502
    [No Abstract]   [Full Text] [Related]  

  • 19. How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: comparison with the unified Parkinson's disease rating scale.
    Stebbins GT; Goetz CG; Burn DJ; Jankovic J; Khoo TK; Tilley BC
    Mov Disord; 2013 May; 28(5):668-70. PubMed ID: 23408503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study on the Clinical Features of Parkinson's Disease With Probable Rapid Eye Movement Sleep Behavior Disorder.
    Long K; Wan C; Xiang Y; Liu J; Xu Q; Sun Q; Wang Z; Tian Y; Fang L; Yang Y; Yan X; Tang B; Guo J
    Front Neurol; 2020; 11():979. PubMed ID: 33041969
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.